Although the subject of infection control is one that is broadly applicable to all ambulatory surgery centers, the issue can take on specific meanings in various settings, including GI-driven ASCs.
This article is written by Jason Wandersee, CEO of MEDISISS, a Medline-owned reprocessing company. MEDISISS is the leader in reprocessing to surgery centers throughout the United States since 1997.By ...
The following article is written by Bradley J. Catalone, MD, director of clinical affairs, and Mary Ann Drosnock, infection control scientist, for Olympus America. Automated endoscope reprocessors ...